Session Abstract – PMWC 2022 Silicon Valley


Join us as we share the latest on respiratory variant trends, and as we discuss how health systems and other organizations can leverage learnings from these past two years as we look beyond the pandemic and towards enabling healthier outcomes for entire communities now and into the future.

 Session Chair Profile

M.D., Ph.D., Chief Executive Officer and Co-Founder, Helix

Biography
James is a co-founder and the Chief Executive Officer at Helix. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. In response to the COVID-19 public health crisis, Helix launched a sensitive and scalable end-to-end COVID-19 test and viral surveillance system to meet the needs of health systems, employers, governments, and other organizations across the country. Prior to Helix, James was a faculty member at Duke University where he focused on translational genomics and machine learning methodologies for electronic medical records. James has also explored a broad range of research topics in population genetics, Mendelian genomics, and computational psychiatry and has published dozens of papers in journals such as Nature, the New England Journal of Medicine and the Journal of Machine Learning Research. Earlier in his career, James was a Lean Six Sigma Black Belt at Merck Pharmaceuticals, a global biopharma company, and an Associate at Devon Park Bioventures, a Philadelphia based healthcare venture capital firm. James holds an M.D. and Ph.D. from Baylor College of Medicine, where he was a member of the Alpha Omega Alpha Honor Society. He also received a B.S. and M.S. in Chemical Engineering from Stanford University.

Talk
Experiences from the Front Lines of a National Viral Surveillance Organization
Join us as we share the latest on respiratory variant trends. We'll discuss how healthcare organizations can leverage learnings to inform predictive analytics and provide real-world evidence, as we look beyond the pandemic and towards enabling healthier outcomes for communities now and into the future.